Scholarlink

Purpose <p>Accurate preoperative grading of gliomas is critical for therapeutic planning and prognostic evaluation. We developed a noninvasive machine learning model leveraging whole-brain resting-state functional magnetic resonance imaging (rs-fMRI) biomarkers to discriminate high-grade (HGGs) and low-grade gliomas (LGGs) in the frontal lobe.</p> Methods <p>This retrospective study included 138 patients (78 LGGs, 60 HGGs) with left frontal gliomas. A total of 7134 features were extracted from the mean amplitude of low-frequency fluctuation (mALFF), mean fractional ALFF, mean percentage amplitude of fluctuation (mPerAF), mean regional homogeneity (mReHo) maps and resting-state functional connectivity (RSFC) matrix. Twelve predictive features were selected through Mann-Whitney U test, correlation analysis and least absolute shrinkage and selection operator method. The patients were stratified and randomized into the training and testing datasets with a 7:3 ratio. The logical regression, random forest, support vector machine (SVM) and adaptive boosting algorithms were used to establish models. The model performance was evaluated using area under the receiver operating characteristic curve, accuracy, sensitivity, and specificity.</p> Results <p>The selected 12 features included 7 RSFC features, 4 mPerAF features, and 1 mReHo feature. Based on these features, the model was established using the SVM had an optimal performance. The accuracy in the training and testing datasets was 0.957 and 0.727, respectively. The area under the receiver operating characteristic curves was 0.972 and 0.799, respectively.</p> Conclusions <p>Our whole-brain rs-fMRI radiomics approach provides an objective tool for preoperative glioma stratification. The biological interpretability of selected features reflects distinct neuroplasticity patterns between LGGs and HGGs, advancing understanding of glioma-network interactions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Machine learning of whole-brain resting-state fMRI signatures for individualized grading of frontal gliomas

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月4日

查看全文
  • Yue Hu,
  • Xin Cao,
  • Hongyi Chen,
  • Daoying Geng,
  • Kun Lv

摘要

Purpose

Accurate preoperative grading of gliomas is critical for therapeutic planning and prognostic evaluation. We developed a noninvasive machine learning model leveraging whole-brain resting-state functional magnetic resonance imaging (rs-fMRI) biomarkers to discriminate high-grade (HGGs) and low-grade gliomas (LGGs) in the frontal lobe.

Methods

This retrospective study included 138 patients (78 LGGs, 60 HGGs) with left frontal gliomas. A total of 7134 features were extracted from the mean amplitude of low-frequency fluctuation (mALFF), mean fractional ALFF, mean percentage amplitude of fluctuation (mPerAF), mean regional homogeneity (mReHo) maps and resting-state functional connectivity (RSFC) matrix. Twelve predictive features were selected through Mann-Whitney U test, correlation analysis and least absolute shrinkage and selection operator method. The patients were stratified and randomized into the training and testing datasets with a 7:3 ratio. The logical regression, random forest, support vector machine (SVM) and adaptive boosting algorithms were used to establish models. The model performance was evaluated using area under the receiver operating characteristic curve, accuracy, sensitivity, and specificity.

Results

The selected 12 features included 7 RSFC features, 4 mPerAF features, and 1 mReHo feature. Based on these features, the model was established using the SVM had an optimal performance. The accuracy in the training and testing datasets was 0.957 and 0.727, respectively. The area under the receiver operating characteristic curves was 0.972 and 0.799, respectively.

Conclusions

Our whole-brain rs-fMRI radiomics approach provides an objective tool for preoperative glioma stratification. The biological interpretability of selected features reflects distinct neuroplasticity patterns between LGGs and HGGs, advancing understanding of glioma-network interactions.